Cargando…

A New Histone Deacetylase Inhibitor, MHY4381, Induces Apoptosis via Generation of Reactive Oxygen Species in Human Prostate Cancer Cells

Histone deacetylase (HDAC) inhibitors represent a novel class of anticancer agents, which can be used to inhibit cell proliferation and induce apoptosis in several types of cancer cells. In this study, we investigated the anticancer activity of MHY4381, a newly synthesized HDAC inhibitor, against hu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Richa, Sachan, Dey, Prasanta, Park, Chaeun, Yang, Jungho, Son, Ji Yeon, Park, Jae Hyeon, Lee, Su Hyun, Ahn, Mee-Young, Kim, In Su, Moon, Hyung Ryong, Kim, Hyung Sik
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society of Applied Pharmacology 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7059815/ https://www.ncbi.nlm.nih.gov/pubmed/31476841 http://dx.doi.org/10.4062/biomolther.2019.074

Ejemplares similares

A New Synthetic Histone Deacetylase Inhibitor, MHY2256, Induces Apoptosis and Autophagy Cell Death in Endometrial Cancer Cells via p53 Acetylation
por: De, Umasankar, et al.
Publicado: (2018)

A New Histone Deacetylase Inhibitor, MHY219, Inhibits the Migration of Human Prostate Cancer Cells via HDAC1
por: De, Umasankar, et al.
Publicado: (2015)

Pro-apoptotic effect of the novel benzylidene derivative MHY695 in human colon cancer cells
por: Heo, Gwangbeom, et al.
Publicado: (2019)

A new SIRT1 inhibitor, MHY2245, induces autophagy and inhibits energy metabolism via PKM2/mTOR pathway in human ovarian cancer cells
por: Tae, In Hwan, et al.
Publicado: (2020)

MHY440, a Novel Topoisomerase Ι Inhibitor, Induces Cell Cycle Arrest and Apoptosis via a ROS-Dependent DNA Damage Signaling Pathway in AGS Human Gastric Cancer Cells
por: Jang, Jung Yoon, et al.
Publicado: (2018)

Evaluation of the Novel Synthetic Tyrosinase Inhibitor (Z)-3-(3-bromo-4-hydroxybenzylidene)thiochroman-4-one (MHY1498) In Vitro and In Silico
por: Bang, EunJin, et al.
Publicado: (2018)

Inhibitory Effect of mTOR Activator MHY1485 on Autophagy: Suppression of Lysosomal Fusion
por: Choi, Yeon Ja, et al.
Publicado: (2012)

Correction: Inhibitory Effect of mTOR Activator MHY1485 on Autophagy: Suppression of Lysosomal Fusion
por: Choi, Yeon Ja, et al.
Publicado: (2013)

Hepatoprotective Effects of MHY3200 on High-Fat, Diet-Induced, Non-Alcoholic Fatty Liver Disease in Rats
por: Kim, Min Jo, et al.
Publicado: (2018)

MHY2233 Attenuates Replicative Cellular Senescence in Human Endothelial Progenitor Cells via SIRT1 Signaling
por: Lamichane, Shreekrishna, et al.
Publicado: (2019)

PPAR Pan Agonist MHY2013 Alleviates Renal Fibrosis in a Mouse Model by Reducing Fibroblast Activation and Epithelial Inflammation
por: Son, Minjung, et al.
Publicado: (2023)

Thiobarbiturate-Derived Compound MHY1025 Alleviates Renal Fibrosis by Modulating Oxidative Stress, Epithelial Inflammation, and Fibroblast Activation
por: Kim, Jeongwon, et al.
Publicado: (2023)

Anticancer Effects of a New SIRT Inhibitor, MHY2256, against Human Breast Cancer MCF-7 Cells via Regulation of MDM2-p53 Binding
por: Park, Eun Young, et al.
Publicado: (2016)

Dendropanax morbifera Protects against Renal Fibrosis in Streptozotocin-Induced Diabetic Rats
por: Sachan, Richa, et al.
Publicado: (2020)

4381 Examination of FDA Pediatric Regulations: Inclusion of Pediatric Populations in Clinical Trials, 2016 - 2018
por: Ly, Annie, et al.
Publicado: (2020)

Potent Anti-Diabetic Effects of MHY908, a Newly Synthesized PPAR α/γ Dual Agonist in db/db Mice
por: Park, Min Hi, et al.
Publicado: (2013)

EX-527 Prevents the Progression of High-Fat Diet-Induced Hepatic Steatosis and Fibrosis by Upregulating SIRT4 in Zucker Rats
por: Kundu, Amit, et al.
Publicado: (2020)

Histone Deacetylases and Their Regulatory MicroRNAs in Hepatocarcinogenesis
por: Kim, Hyung Seok, et al.
Publicado: (2015)

Human cardiac stem cells rejuvenated by modulating autophagy with MHY-1685 enhance the therapeutic potential for cardiac repair
por: Park, Ji Hye, et al.
Publicado: (2021)

Novel PPARα agonist MHY553 alleviates hepatic steatosis by increasing fatty acid oxidation and decreasing inflammation during aging
por: Kim, Seong Min, et al.
Publicado: (2017)

The Novel PPAR α/γ Dual Agonist MHY 966 Modulates UVB–Induced Skin Inflammation by Inhibiting NF-κB Activity
por: Park, Min Hi, et al.
Publicado: (2013)

Author Correction: Human cardiac stem cells rejuvenated by modulating autophagy with MHY-1685 enhance the therapeutic potential for cardiac repair
por: Park, Ji Hye, et al.
Publicado: (2022)

MHY2245, a Sirtuin Inhibitor, Induces Cell Cycle Arrest and Apoptosis in HCT116 Human Colorectal Cancer Cells
por: Kang, Yong Jung, et al.
Publicado: (2022)

Cytoprotective Roles of a Novel Compound, MHY-1684, against Hyperglycemia-Induced Oxidative Stress and Mitochondrial Dysfunction in Human Cardiac Progenitor Cells
por: Jang, Woong Bi, et al.
Publicado: (2018)

Epigenetic Targeting of Histone Deacetylases in Diagnostics and Treatment of Depression
por: Park, Hyun-Sun, et al.
Publicado: (2021)

Anti-Inflammatory Effects of the Novel Barbiturate Derivative MHY2699 in an MPTP-Induced Mouse Model of Parkinson’s Disease
por: Lee, Seulah, et al.
Publicado: (2021)

PPARα Agonist, MHY3200, Alleviates Renal Inflammation during Aging via Regulating ROS/Akt/FoxO1 Signaling
por: Kim, Min Jo, et al.
Publicado: (2021)

MHY2251, a New SIRT1 Inhibitor, Induces Apoptosis via JNK/p53 Pathway in HCT116 Human Colorectal Cancer Cells
por: Kang, Yong Jung, et al.
Publicado: (2023)

Novel SIRT Inhibitor, MHY2256, Induces Cell Cycle Arrest, Apoptosis, and Autophagic Cell Death in HCT116 Human Colorectal Cancer Cells
por: Kim, Min Jeong, et al.
Publicado: (2020)

Biological Evaluation of Oxindole Derivative as a Novel Anticancer Agent against Human Kidney Carcinoma Cells
por: Dey, Prasanta, et al.
Publicado: (2020)

Novel Histone Deacetylase 6 Inhibitor Confers Anti-inflammatory Effects and Enhances Gut Barrier Function
por: Lee, Jae-Young, et al.
Publicado: (2023)

Histone Deacetylases and Histone Deacetylase Inhibitors in Neuroblastoma
por: Phimmachanh, Monica, et al.
Publicado: (2020)

The antidepressant action of 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid is mediated by phosphorylation of histone deacetylase 5
por: Park, Min Hyeop, et al.
Publicado: (2018)

Structural basis of the specific interaction of SMRT corepressor with histone deacetylase 4
por: Park, Suk-Youl, et al.
Publicado: (2018)

A new histone deacetylase inhibitor improves liverfibrosis in BDL rats through suppression of hepatic stellate cells
por: Park, Ki Cheong, et al.
Publicado: (2014)

MHY4571, a novel diarylcyclohexanone derivative, exerts anti-cancer activity by regulating the PKA-cAMP-response element-binding protein pathway in squamous cell lung cancer
por: Chung, Jae Heun, et al.
Publicado: (2022)

The Impact of Androgen Receptor and Histone Deacetylase 1 Expression on the Prognosis of Ductal Carcinoma In Situ
por: Lee, Choong Man, et al.
Publicado: (2020)

Physiological characterization of a novel PPAR pan agonist, 2-(4-(5,6-methylenedioxybenzo[d]thiazol-2-yl)-2-methylphenoxy)-2-methylpropanoic acid (MHY2013)
por: An, Hye Jin, et al.
Publicado: (2017)

Oleanolic Acid Promotes Neuronal Differentiation and Histone Deacetylase 5 Phosphorylation in Rat Hippocampal Neurons
por: Jo, Hye-Ryeong, et al.
Publicado: (2017)

Beyond Histone and Deacetylase: An Overview of Cytoplasmic Histone Deacetylases and Their Nonhistone Substrates
por: Yao, Ya-Li, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_bf0gatkp5gpiuvhlmecsklepav